Satellos Bioscience (MSLE) Share-based Compensation (2025 - 2026)
Satellos Bioscience's (MSLE) quarterly Share-based Compensation came in at $727000.0 in Q1 2026, up 13.24% year-on-year from $642000.0 in Q1 2025, and up 13.24% on a QoQ basis from $642000.0 in Q1 2025.
Satellos Bioscience (MSLE) Share-based Compensation (2025 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has 2 years of Share-based Compensation data on file, last reported at $727000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 305,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9.26 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 87.30 Mn |
| 10 | Satellos Bioscience | 175.69 Mn | 175.69 Mn | - | 727,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 727,000.00 |
| Mar 31, 2026 | 727,000.00 |
| Mar 31, 2025 | 642,000.00 |
| Mar 31, 2025 | 642,000.00 |